← Leaderboards
Abigail Smith
Northwestern University At Chicago
$2,712,071
Attributed
$8,136,214
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.1M · FY2022–25$5M$3.8M$2.5M$1.3M$0
'22
'23
'24
'25
Funding mix
By agency
NIH$8,136,214 · 3
By mechanism
U24$5,421,511 · 2
R01$2,714,703 · 1
Top collaborators
- Alexander Paul Glaser5 shared
- James William Griffith5 shared
- Crystal A. Gadegbeku4 shared
- Laura H Mariani4 shared
- Lauren Balmert Bonner1 shared
- Daniela P Ladner1 shared
Most similar at Northwestern University At Chicago
Same institution · by research overlap
- Melissa A. Simon$40,197,785
- Joseph M Feinglass$775
- Mark D Huffman$8,566,817
- Dike Bevis Ojji$6,248,787
- Claudia A Hawkins$3,989,292
Others in their field
Other Rising Stars on “Diagnosis”
- David Annett · Information Management Services, Inc.$35,571,865
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Jennifer Lee O'Brien · University Of South Florida$15,110,862
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
- Thomas K Karikari · Wake Forest University Health Sciences$14,340,584
- John Alam · Eip Pharma, Inc.$10,411,018
Research focus
DiagnosisFollow-UpPatient Outcomes AssessmentsPatient CareTreatment ResponseModernizationClinicElectronic Health RecordDesignMedicalReduce SymptomsProviderSymptom TreatmentMonitorCaringOperative Surgical ProceduresComorbidityAmericanComplexCost EffectiveBenign Prostatic HypertrophyCare CoordinationEffective TherapyClinical Decision-Making
Grant awards (10)
Liver Cirrhosis Network: Scientific and Data Coordination Center$1,911,512
U24 · FY2025 · DK · contact PI
CureGN$1,400,000
U24 · FY2025 · DK
Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes$600,253
R01 · FY2025 · DK
CureGN$224,000
U24 · FY2025 · DK
CureGN$1,399,999
U24 · FY2024 · DK
Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes$629,661
R01 · FY2024 · DK
CureGN$486,000
U24 · FY2024 · DK
Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes$669,698
R01 · FY2023 · DK
Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes$99,997
R01 · FY2023 · DK
Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes$715,094
R01 · FY2022 · DK